Executive Summary
The Chinese equity market witnessed a monumental shift in capital allocation in 2025, with exchange-traded funds (ETFs) acting as the primary conduit for institutional and retail investment.
– A historic 1.18 trillion yuan net flowed into all listed ETFs in 2025, signaling massive confidence in the instrument’s structure and underlying themes.
– Capital concentration intensified in December, decisively favoring the broad-based A500 index and innovative Sci-Tech Innovation bonds, with single-ETF monthly inflows exceeding 20 billion yuan.
– The growth versus value divide was stark: semiconductors, healthcare, and technology ETFs soared while traditional banking, oil, and high-dividend (红利) themes lagged.
– Forward-looking fund managers highlight a 2026 outlook centered on selective growth in AI, healthcare, and new consumption, alongside a potential valuation rerating for Hong Kong-listed stocks amid anticipated global monetary easing.
A Powerful Start to the Year Signals Sustained Rotation
The first trading week of the new year provided a clear continuation of the powerful thematic trends that defined the closing quarter of 2025. On January 5th, Chinese equities exhibited a pronounced growth-style leadership, with the pharmaceuticals and semiconductor sectors staging particularly impressive rallies. Several thematic ETFs tracking these industries surged over 5% in a single session, decisively outperforming the broader market. This momentum was not isolated; complementary strength was seen in gold, non-ferrous metals, defense, and Hong Kong-listed consumer stocks.
Conversely, the session underscored a ongoing capital rotation away from previously favored defensive and yield-oriented sectors. ETFs focused on banking, petroleum, and high-dividend (红利) strategies displayed notable weakness. This dichotomy sets the stage for understanding the larger, trillion-yuan narrative of capital reallocation that unfolded throughout the preceding year. The initial market action confirms that the forces driving this historic trillion yuan pours into A-shares remain potent and focused on forward-looking growth narratives.
The Underlying Data: A Year of Record ETF Inflows
The scale of the movement is staggering. Wind data reveals that across the entire market, all ETFs collectively attracted a net inflow of 1,178.599 billion yuan in 2025. This figure is not merely a statistic; it represents a fundamental shift in how capital is being deployed within China’s financial markets. ETFs have evolved from niche products to central pillars of market liquidity and thematic investment. This historic inflow suggests deep-seated investor appetite for diversified, transparent, and cost-effective exposure to specific sectors and strategies, particularly as market volatility and sector rotation intensify.
December 2025: The Month of Mega-Concentration
If 2025 was the year of the ETF, December was the month when capital made its most concentrated and decisive bets. Analysis of monthly net inflow data pinpointed two dominant destinations: the A500 Index and Sci-Tech Innovation Corporate Bonds.
The A500 Index, designed to represent the broad middle market capitalization segment of the A-share universe, became a magnet for institutional capital. It offers a compelling alternative to the large-cap heavy CSI 300, capturing a wider array of potential growth leaders.
– Southern China CSI A500 ETF: Monthly net inflow exceeding 20 billion yuan.
– Huatai-PineBridge CSI A500 ETF: Monthly net inflow exceeding 20 billion yuan.
– ChinaAMC CSI A500 ETF: Monthly net inflow exceeding 20 billion yuan.
Simultaneously, the hunt for yield and innovation converged in the bond market. The Sci-Tech Innovation bond theme, which focuses on debt issued by high-tech and innovative companies, saw enormous demand. This reflects a strategic search for stable income within the growth ecosystem, diversifying away from pure equity risk.
– Harvest China Securities AAA Sci-Tech Innovation Corporate Bond ETF: Monthly net inflow exceeding 20 billion yuan.
– Yinhua China Securities AAA Sci-Tech Innovation Corporate Bond ETF: Monthly net inflow nearing 19 billion yuan.
This dual-pronged assault of capital into a broad equity index and a targeted innovative bond segment highlights a sophisticated two-part strategy: gaining diversified growth equity exposure while layering in lower-volatility, income-generating assets from the same innovative economic engine. This is a key facet of how the trillion yuan pours into A-shares is being tactically implemented.
The 2025 Champions: ETFs That Captured the Mega-Flows
Zooming out to the full year, a handful of ETF champions emerged, each attracting over 40 billion yuan in net new capital. These winners tell the story of 2025’s dominant investment narratives.
– Fullgoal China Hong Kong Stock Connect Internet ETF (富国中证港股通互联网ETF): The clear leader, with annual net inflows surpassing 56 billion yuan. This underscores the enduring, though volatile, appeal of China’s platform economy giants, especially as regulatory pressures have eased and fundamentals have improved.
– Huaan Gold ETF (华安黄金ETF): With inflows over 40 billion yuan, this reflects a global macro hedge. Investors sought safety in hard assets amid geopolitical uncertainty and as a potential beneficiary of future Federal Reserve rate cuts.
– Harvest China Securities AAA Sci-Tech Innovation Corporate Bond ETF (嘉实中证AAA科技创新公司债ETF): Its standout December performance capped a stellar year with total inflows also exceeding 40 billion yuan, confirming the strong appetite for innovative credit.
– HFT China Securities Short-term Financing Bill ETF (海富通中证短融ETF): Another fixed-income champion, its 40-billion-yuan-plus haul points to demand for high-quality, short-duration liquidity tools in a complex rate environment.
Beyond these top four, themes like the CSI 300, the A500, and Hong Kong Stock Connect non-bank financials also ranked highly on investors’ buy lists. The collective movement of this trillion yuan pours into A-shares and related assets reveals a portfolio construction mindset balancing growth (Internet, Tech Bonds), defense (Gold), and liquidity (Short-term Bills).
Sector Deep Dive: Healthcare and Semiconductors in the Spotlight
港股医药板块表现强势 (Hong Kong Healthcare Sector Shows Strong Performance)
The January 5th rally in healthcare, particularly among Hong Kong-listed biotech and medical device companies, was dramatic. ETFs like the Fullgoal Hong Kong Stock Connect Healthcare ETF (港股通医疗ETF富国) jumped over 7%. This surge is rooted in a fundamental re-rating of the sector’s prospects.
According to Harvest Fund Manager Zhang Chaoliang (张超梁), who manages a Hong Kong Stock Connect Innovative Pharma ETF, the sector is now at an attractive valuation following its extended adjustment. The investment thesis for innovative drug companies has evolved. “The logic for innovative drugs going overseas is different from before,” he notes. “After the launch of major drug pipelines, they can sustainably contribute royalty income, improving corporate cash flow. The performance of some leading pharmaceutical companies is beginning to materialize.”
He further emphasizes that Hong Kong’s status as a listing hub for biotech companies provides a continuous pipeline of new entrants, injecting dynamism into the sector. This combination of valuation appeal, improving fundamentals, and fresh supply creates a compelling growth narrative that is capturing a significant share of investor attention.
半导体赛道行情火热 (Semiconductor Sector Heats Up)
Parallel to healthcare, the semiconductor ecosystem was ablaze. Thematic ETFs in semiconductors, big data, AI, and cloud computing all posted strong gains, with many chip-focused funds rising over 5%. This reflects both cyclical recovery hopes and powerful secular tailwinds from national strategic priorities.
Jinxin Fund provides a clear-eyed framework for future investment within the sector, identifying three core directions where the trillion yuan pours into A-shares is likely to find further opportunities:
1. Domestic Lithography and Core Supply Chain: The highest-priority strategic segment, focused on achieving self-sufficiency in advanced chip manufacturing equipment.
2. Front-end, Low Domestic Penetration Core Tracks: This includes semiconductor manufacturing equipment, core materials, and high-end chip design—areas where import substitution is critical and ongoing.
3. Medium-to-Low Penetration Growth Segments: Specific process equipment like etching, thin-film deposition, and bonding, which are experiencing rapid adoption within China’s expanding fabrication capacity.
This structured analysis moves beyond generic optimism, offering investors a roadmap to specific sub-sectors poised for growth driven by both policy and capital expenditure cycles.
Market Outlook and Strategic Implications for 2026
As the market digests the historic flows of 2025, attention swiftly turns to the implications for the coming year. Fund houses are building their 2026 strategies on a foundation of cautious optimism, with a clear focus on selectivity.
港股公司盈利有望回暖 (Hong Kong-Listed Company Earnings May Recover)
Hwabao WP Fund presents a nuanced outlook for the Hong Kong market. They anticipate a potential recovery in corporate earnings, albeit with structural divergence. Sectors benefiting from overseas demand (like non-ferrous metals) or industry leaders with strong competitive moats (internet, consumer, industrials) are expected to exhibit greater profit elasticity.
Perhaps more significantly, they highlight a favorable shift in liquidity conditions. “The risk-free interest rate anchoring Hong Kong stocks is likely to decline, and Hong Kong market liquidity is expected to become more accommodative,” they state. The probable commencement of a U.S. Federal Reserve rate-cutting cycle in 2026 could strengthen global risk assets. If rate cuts exceed expectations, coupled with a weaker U.S. dollar and potential Renminbi appreciation, Hong Kong equities could experience a meaningful valuation uplift from improved liquidity.
For investment direction, Hwabao WP Fund identifies AI, new consumption, healthcare, and high-dividend (红利) strategies as key focus areas for 2026—a blend of growth and defensive income that mirrors the broader flow trends of 2025.
Navigating Cross-Border ETF Premiums and Risks
The intense demand for certain themes has manifested in dramatic premiums for some cross-border ETFs. On January 5th, products like the Nasdaq Technology ETF (159509) traded at a premium exceeding 20% to their net asset value. This prompted multiple fund managers to issue urgent risk announcements after the market closed, warning investors of the dangers of paying excessive premiums in the secondary market. This phenomenon serves as a critical reminder that while thematic investing via ETFs is powerful, execution and price discipline remain paramount. The rush of capital can create short-term distortions that savvy investors must navigate cautiously. You can review such official risk announcements on the Shenzhen Stock Exchange (深圳证券交易所) disclosure platform.
Synthesizing the Trillion-Yuan Signal
The story of 2025 is unequivocally one of strategic capital reallocation on a grand scale. The record trillion yuan pours into A-shares and related ETFs was not a indiscriminate flood but a targeted deployment towards themes representing China’s economic transformation: technological self-reliance (semiconductors, Sci-Tech bonds), the future of health (biotech), digital dominance (internet platforms), and prudent macro hedging (gold). The late-year sprint into the A500 and Sci-Tech bonds indicates a maturation of this trend, favoring diversified growth exposure and innovative fixed income.
For global investors and fund managers, the takeaways are actionable. First, ETF flows have become a crucial real-time indicator of domestic Chinese institutional sentiment and thematic momentum. Second, the growth/value rotation has firm fundamental and flow-based support, suggesting continued divergence. Third, the Hong Kong market, particularly in sectors like healthcare and internet, may offer a compelling valuation and liquidity-driven opportunity in 2026 as global monetary policy pivots.
The call to action is clear: Move beyond broad market generalizations. Scrutinize ETF flow data, understand the specific sub-sector narratives within mega-themes like semiconductors and healthcare, and position portfolios to align with the strategic directions where Chinese capital itself is flowing most persistently. The trillion-yuan trail has been blazed; the task now is to follow it with discernment.